EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nirmatrelvir/Ritonavir and Subsequent PCR Negativity in Patients With B‐Cell Lymphoma and Prolonged SARS‐CoV‐2 PCR Positivity: A Case Series

Yutaka Natori, Hideyoshi Noji, Akiko Shichishima-Nakamura, Satoru Kikuchi, Shigehira Saji

eJHaem · 2026-10 · 7 (5)

DOI: 10.1002/jha2.70442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 24.10.2026. Verfasst von Yutaka Natori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology Fukushima Medical University Fukushima Japan. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolonged SARS‐CoV‐2 PCR positivity is increasingly recognized in immunocompromised patients. We retrospectively analyzed four patients with B‐cell lymphoma and prior anti‐CD20 antibody therapy who exhibited prolonged PCR positivity after COVID‐19 diagnosis. The median duration of PCR positivity was 57 days (range, 47–78 days); lymphoma treatment was interrupted in one patient and could not be resumed in another. Three patients received nirmatrelvir/ritonavir and became PCR negative 5–14 days after treatment initiation. These findings suggest that prolonged SARS‐CoV‐2 PCR positivity may disrupt lymphoma treatment and that PCR negativity was observed shortly after nirmatrelvir/ritonavir treatment in selected patients.

Schlagwörter

Stichwörter der Autor:innen

B‐cell lymphomaCOVID‐19SARS‐CoV‐2case reportprolonged PCR positivity

Autor:innen und Institutionen

  • Department of Medical Oncology Fukushima Medical University Fukushima Japan.
  • Department of Hematology Fukushima Minami Hospital Fukushima Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Natori, Y., Noji, H., Shichishima-Nakamura, A., Kikuchi, S., & Saji, S. (2026). Nirmatrelvir/Ritonavir and Subsequent PCR Negativity in Patients With B‐Cell Lymphoma and Prolonged SARS‐CoV‐2 PCR Positivity: A Case Series. eJHaem, 7(5). https://doi.org/10.1002/jha2.70442

Vancouver

Natori Y, Noji H, Shichishima-Nakamura A, Kikuchi S, Saji S. Nirmatrelvir/Ritonavir and Subsequent PCR Negativity in Patients With B‐Cell Lymphoma and Prolonged SARS‐CoV‐2 PCR Positivity: A Case Series. eJHaem. 2026;7(5). doi:10.1002/jha2.70442

BibTeX
@article{Natori2026,
  author = {Natori, Yutaka and Noji, Hideyoshi and Shichishima-Nakamura, Akiko and Kikuchi, Satoru and Saji, Shigehira},
  title = {Nirmatrelvir/Ritonavir and Subsequent PCR Negativity in Patients With B‐Cell Lymphoma and Prolonged SARS‐CoV‐2 PCR Positivity: A Case Series},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {5},
  doi = {10.1002/jha2.70442}
}
Kostenlos starten →